Why is Chemo Pharma Lab falling/rising?

As of 06-Oct, Chemo Pharma Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 126.00, which reflects a decrease of Rs 6.0 or 4.55%. The stock has underperformed its sector today by 4.52% and has fallen after two consecutive days of gains. It reached an intraday low of Rs 125.3, indicating a significant drop of 5.08%. Despite this decline, the stock has shown strong performance over the longer term, with a year-to-date increase of 14.71% and an impressive 90.91% rise over the past year. Additionally, the stock is trading above its moving averages across various time frames, suggesting a generally positive trend prior to this drop. However, the recent increase in delivery volume by 897.66% on October 3 indicates rising investor participation, which could be a positive sign for future performance.
In the broader market context, Chemo Pharma's short-term performance over the past week shows a gain of 3.36%, which is significantly higher than the Sensex's increase of 1.77%. This outperformance in the short term contrasts with the current day's decline, highlighting a potential trend reversal. The stock's liquidity remains adequate for trading, as it is based on 2% of the five-day average traded value. Overall, while the stock has faced a setback today, its strong historical performance and increased investor interest may provide a foundation for recovery in the near future.